<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Tiansheng (Tian) Wang â€” Pharmacoepidemiology â€¢ Causal Inference â€¢ ML</title>
  <meta name="description" content="Assistant Professor (PHOP, UH). Pharmacoepidemiology, AI-powered causal inference, machine learning, real-world data." />

  <!-- Fonts + shared styles -->
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700;800&display=swap" rel="stylesheet">
  <link rel="stylesheet" href="/assets/styles.css">

  <!-- Favicon -->
  <link rel="icon" href="/images/favicon.jpg" sizes="32x32">
  <link rel="icon" type="image/svg+xml" href="/images/favicon.svg">
</head>
<body>

<header>
  <div class="container">
    <nav>
      <div class="brand">Tiansheng (Tian) Wang</div>
      <div class="nav">
        <a href="#home">Home</a>
        <a href="/lab.html">CausalRx.AI Lab</a>
        <a href="/software.html">Software</a>
        <a href="/publications.html">Publications</a>
        <a href="/gallery.html">Gallery</a>
        <button id="themeToggle" class="toggle" aria-label="Toggle light/dark">ðŸŒ™</button>
      </div>
    </nav>
  </div>
</header>

<main>
  <!-- Hero -->
  <section class="hero reveal" id="home">
    <div class="blob b1"></div>
    <div class="blob b2"></div>
    <div class="container grid">
      <div>
        <h1 class="title">Tiansheng Wang, PharmD, PhD</h1>
        <p class="subtitle" style="margin-top:16px;">
          Assistant Professor in Pharmacoepidemiology. 
        </p>
        <!-- Social icons -->
        <div style="margin:8px 0;">
          <a href="mailto:tianwang@uh.edu" target="_blank"><img src="/images/icons/mail.jpg" alt="Email" style="width:24px;height:24px;margin-right:8px;"></a>
          <a href="https://github.com/tianshengwang" target="_blank"><img src="/images/icons/github.jpg" alt="GitHub" style="width:24px;height:24px;margin-right:8px;"></a>
          <a href="https://www.linkedin.com/in/tiansheng-wang-194a3460" target="_blank"><img src="/images/icons/linkedin.jpg" alt="LinkedIn" style="width:24px;height:24px;margin-right:8px;"></a>
          <a href="https://x.com/_tianshengwang" target="_blank"><img src="/images/icons/x.jpg" alt="X" style="width:24px;height:24px;margin-right:8px;"></a>
          <a href="https://scholar.google.com/citations?user=JYtT5K8AAAAJ&hl=en" target="_blank"><img src="/images/icons/google-scholar.jpg" alt="Google Scholar" style="width:24px;height:24px;"></a>
        </div>

        <!-- Affiliations -->
        <table style="margin-top:16px;border-collapse:collapse;">
          <tr>
            <td style="padding:4px 8px;font-weight:bold;">Assistant Professor</td>
            <td style="padding:4px 8px;">University of Houston College of Pharmacy<br>Department of Pharmaceutical Health Outcomes and Policy</td>
          </tr>
          <tr>
            <td style="padding:4px 8px;font-weight:bold;">Adjunct Assistant Professor</td>
            <td style="padding:4px 8px;">...</td>
          </tr>
        </table>

        <p class="subtitle" style="margin-top:16px;">
          Iâ€™m an Assistant Professor in the Department of Pharmaceutical Health Outcomes and Policy at the University of Houston College of Pharmacy. 
          I develop and apply <strong>AI-powered causal inference</strong> methods to learn what works (or harms) from real-world data,
  with emphasis on <strong>precision medicine</strong>, <strong>confounding control</strong>, and <strong>using multimodal data (genetics, imaging, real-world data) to assess drug effects</strong>.
          I earned my Ph.D. in Epidemiology and completed a postdoc training at University of North Carolina at Chapel Hill, working with
            <a href="https://sph.unc.edu/adv_profile/til-sturmer-md-phd/" target="_blank" rel="noopener noreferrer">Dr. Til StÃ¼rmer</a>, 
            <a href="https://sph.unc.edu/adv_profile/michael-r-kosorok-phd/" target="_blank" rel="noopener noreferrer">Dr. Michael Kosorok</a>,
            <a href="https://www.med.unc.edu/medicine/endocrinology-metabolism/people/john-buse-md-phd/" target="_blank" rel="noopener noreferrer">Dr. John Buse</a>, and 
            <a href="https://www.med.unc.edu/neurology/people/gwenn-a-garden-md-phd/" target="_blank" rel="noopener noreferrer">Dr. Gwenn Garden.</a>
          Prior to my academic career in the U.S., I was a Lecturer at Peking University and also practiced as a pharmacist in the U.S..
        </p>
        
        <p class="subtitle" style="margin-top:16px;">
  <strong>I have openings for postdocs to apply causal inference and machine learning methods assessing drug effects, 
  supported by my recent UH new faculty and Alzheimerâ€™s Association & NACC new investigator award grants</strong>.
        </p>
        
      </div>
      <div class="avatarWrap">
        <img class="avatar" src="/images/Tian_UHAP23.jpg" alt="Tiansheng (Tian) Wang portrait" />
      </div>
    </div>
  </section>

  <!-- Latest News -->
  <section id="latest-news" class="reveal">
    <div class="container">
      <h2>Latest News</h2>
      <ul>
        <li>
        <strong>Sep 2025:</strong> Honored to receive the Alzheimerâ€™s Association & NACC New Investigators Award.
      </li>
        <li><strong>Sep 2025:</strong> Start tenure track assistant professor position at Dept. of Pharmaceutical Health Outcomes and Policy, University of Houston College of Pharmacy.</li>
        <li><strong>Aug 2025:</strong> 
          <i class="fa-solid fa-microphone" style="color:#c8102e; margin-right:6px;"></i> 
          Present at ISPE 2025 on developing novel methods for confounding control using longitudinal pattern at baseline period.
          <strong>Talk 1</strong>: preventative drug trajectories for confounding control;
          <strong>Talk 2</strong>: temporal high-dimensional propensity score. </li>
      </ul>
    </div>
  </section>

  <!-- Active Research Areas -->
  <section id="active-research" class="reveal">
    <div class="container">
      <h2>Active Research Areas</h2>

      <!-- Panel 1 -->
      <div class="panel">
        <h3>Precision Medicine</h3>
        
        <div class="panel-items">
          <article class="paper">
            <div class="meta">
              <ul>
                <li><a href="https://doi.org/10.1093/aje/kwad219" target="_blank"><strong>Iterative Causal Forest (iCF)</strong></a> â€” <em>Am J Epidemiol</em>, 2024</li>
                  We've developed a machine learning subgrouping algorithm based on causal forest to better identify subpopulation who will benefit (or be harmed) more from a specific treatment.
                  The iCF algorithm itertively develop shallow causal forest at different depth to obtain a family of subgroup decisions, 
                  then pick the cross-validated subgroup decision that best predicts causal treatment effect as the final output (subgroup decision). 
                  We have shown promising results in both simulaiton and real-world scenarios.
              </ul>
            </div>
            <figure class="figure-card">
              <img src="/images/figures/FIGURE1_all_Panels_AB.jpg" alt="iCF workflow">
              <figcaption class="caption">iCF workflow</figcaption>
            </figure>
          </article>

          <article class="paper">
            <div class="meta">
              <ul>
                <li><a href="https://doi.org/10.1093/aje/kwae322" target="_blank"><strong>High-dimensional Iterative Causal Forest (hdiCF)</strong></a> â€” <em>Am J Epidemiol</em>, 2024</li>
                We have developed hdiCF, the high-dimensional extension of our iterative Causal Forest (iCF) algorithm. 
                hdiCF uses diagnosis/procedure/prescription codes (ie, does not require predefined covariates) to identify subgroups with heterogeneous treatment effects in claims data. 
                We demonstrate its utility using a case study of SGLT2i and hospitalized heart failure.
              </ul>
            </div>
            <figure class="figure-card">
              <img src="/images/figures/FIGURE1_hdiCF_3KEYsteps.jpg" alt="hdiCF schematic">
              <figcaption class="caption">hdiCF workflow</figcaption>
            </figure>
          </article>

          <article class="paper">
            <div class="meta">
              <ul>
                <li><a href="https://doi.org/10.1093/aje/kwaf127" target="_blank"><strong>High-dimensional method for assessing heterogeneous treatment effect in Claims</strong></a> â€” <em>Am J Epidemiol</em>, 2025</li>
                We introduced a new high-dimensional setting (one ordinal variable per diagnosis/procedure/prescription code) to better identify and evaluate treatment effect heterogeneity in large real-world datasets.
              </ul>
            </div>
            <figure class="figure-card">
              <img src="/images/figures/FIG2_HDsetting_comparison.jpg" alt="High-dimensional blocks">
              <figcaption class="caption">comparing 2 HD settings</figcaption>
            </figure>
          </article>
        </div>
      </div>

      <!-- Panel 2 -->
      <div class="panel">
        <h3>Confounding Control</h3>
        <div class="panel-items">
          <article class="paper">
            <div class="meta">
              <ul>
                <li><a href="https://doi.org/10.1093/aje/kwaf044" target="_blank"><strong>Caution in Handling Switchers in Pharmacoepidemiologic Studies Estimating Treatment Effects</strong></a> â€” <em>Am J Epidemiol</em>, 2025</li>
                We highlighted the study design flaw in a specific type of "time-varying exposure" design, 
                  which only allows indiviudals from comparator group switch to treatment group but not the other way around (asymmetrical follow-up), thus induces time-related bias
                  Our findings emphasize how different approaches to switchers can meaningfully affect study conclusions, underscoring the importance of robust study designs for confounding control.
              </ul>
            </div>
            <figure class="figure-card">
              <img src="/images/figures/Fig1_ACNUvsTVE_v3.jpg" alt="Switchers vs strategies">
              <figcaption class="caption">Handling switchers by different study designs</figcaption>
            </figure>
          </article>

          <article class="paper">
            <div class="meta">
              <ul>
                <li><strong>Temporal pattern for confoudning control</strong></li>
                Work in progress, more coming soon.
              </ul>
            </div>
            <figure class="figure-card">
              <img src="/images/figures/trajectory.jpg" alt="thdPS timeline">
              <figcaption class="caption">longitudinal pattern for confounding control</figcaption>
            </figure>
          </article>
        </div>
      </div>

      <!-- Panel 3 -->
      <div class="panel">
        <h3>Using multimodal data (genetics, imaging, real-world data) to assess drug effects.</h3>
        <div class="panel-items">
          <article class="paper">
            <div class="meta">
              <ul>
                <li><a href="https://doi.org/10.1093/aje/kwaf166" target="_blank"><strong>Claims-based Dementia Identification Algorithm</strong></a> â€” <em>Am J Epidemiol</em>, 2025</li>
                Using Medicare claims from participants of the Atherosclerosis Risk in Communities (ARIC) Study and ARICâ€™s rigorous syndromic dementia classification, 
                we developed and validated algorithms using Medicare claims to identify incident and prevalent dementia, 
                addresseing a key need in pharmacoepidemiology and aging research. 
                It is an important step for improving the accuracy of real-world data studies assessing drug effects on preventing dementia
              </ul>
            </div>
            <figure class="figure-card">
              <img src="/images/figures/Fig3_StudyDesignTimeline_Dementia.jpg" alt="ADRD algorithm timeline">
              <figcaption class="caption">ADRD identification timeline</figcaption>
            </figure>
          </article>
          
             <article class="paper">
            <div class="meta">
              <ul>
                <li><strong>Deep learning-powered neuroimaging analysis to assess drug effects on dementia</strong></li>
                Work in progress, more coming soon.
              </ul>
            </div>
            <figure class="figure-card">
              <img src="/images/figures/imaging_ADRD.jpg" alt="thdPS timeline">
              <figcaption class="caption">Neuroimaging data to assess drug effects</figcaption>
            </figure>
          </article>
        </div>
      </div>
    </div>
  </section>
</main>

<!-- Contact -->
<section id="contact" class="reveal">
  <div class="container">
    <h2>Contact</h2>
    <p><strong>Email:</strong> <a href="mailto:tianwang@uh.edu">tianwang@uh.edu</a> Â· <strong>GitHub:</strong> <a href="https://github.com/tianshengwang" target="_blank">@tianshengwang</a></p>
    <p style="color:#7c869a">Â© <span id="year"></span> Tiansheng (Tian) Wang â€” Built with vanilla HTML/CSS, animated blobs, and scroll-reveal âœ¦ Hosted on GitHub Pages.</p>
  </div>
</section>

<button id="toTop" class="toTop" aria-label="Back to top">â†‘</button>

<!-- Shared JS -->
<script defer src="/assets/site.js"></script>
</body>
</html>

